Scinai Immunotherapeutics (SCNI) Competitors $3.46 +0.08 (+2.37%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$3.40 -0.06 (-1.73%) As of 02/21/2025 05:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends SCNI vs. CHRO, BCDA, AEON, KPRX, TSBX, TLPH, BCLI, PHXM, CSCI, and AIMDShould you be buying Scinai Immunotherapeutics stock or one of its competitors? The main competitors of Scinai Immunotherapeutics include Chromocell Therapeutics (CHRO), BioCardia (BCDA), AEON Biopharma (AEON), Kiora Pharmaceuticals (KPRX), Turnstone Biologics (TSBX), Talphera (TLPH), Brainstorm Cell Therapeutics (BCLI), PHAXIAM Therapeutics (PHXM), COSCIENS Biopharma (CSCI), and Ainos (AIMD). These companies are all part of the "pharmaceutical products" industry. Scinai Immunotherapeutics vs. Chromocell Therapeutics BioCardia AEON Biopharma Kiora Pharmaceuticals Turnstone Biologics Talphera Brainstorm Cell Therapeutics PHAXIAM Therapeutics COSCIENS Biopharma Ainos Chromocell Therapeutics (NYSE:CHRO) and Scinai Immunotherapeutics (NASDAQ:SCNI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership, dividends and community ranking. Do analysts recommend CHRO or SCNI? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chromocell Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Scinai Immunotherapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders believe in CHRO or SCNI? 78.0% of Chromocell Therapeutics shares are owned by institutional investors. Comparatively, 58.4% of Scinai Immunotherapeutics shares are owned by institutional investors. 16.4% of Chromocell Therapeutics shares are owned by insiders. Comparatively, 60.9% of Scinai Immunotherapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media prefer CHRO or SCNI? In the previous week, Chromocell Therapeutics' average media sentiment score of 0.00 equaled Scinai Immunotherapeutics'average media sentiment score. Company Overall Sentiment Chromocell Therapeutics Neutral Scinai Immunotherapeutics Neutral Which has preferable earnings & valuation, CHRO or SCNI? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChromocell TherapeuticsN/AN/A-$7.38MN/AN/AScinai ImmunotherapeuticsN/AN/A-$6.50M-$239.17-0.01 Does the MarketBeat Community prefer CHRO or SCNI? Chromocell Therapeutics received 1 more outperform votes than Scinai Immunotherapeutics when rated by MarketBeat users. CompanyUnderperformOutperformChromocell TherapeuticsOutperform Votes1100.00% Underperform VotesNo VotesScinai ImmunotherapeuticsN/AN/A Is CHRO or SCNI more profitable? Company Net Margins Return on Equity Return on Assets Chromocell TherapeuticsN/A N/A -453.90% Scinai Immunotherapeutics N/A N/A -30.48% SummaryChromocell Therapeutics beats Scinai Immunotherapeutics on 4 of the 7 factors compared between the two stocks. Get Scinai Immunotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SCNI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCNI vs. The Competition Export to ExcelMetricScinai ImmunotherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.88M$3.11B$5.84B$9.15BDividend YieldN/A1.55%4.75%3.85%P/E Ratio-0.0129.6426.1519.13Price / SalesN/A329.47435.3370.72Price / CashN/A168.8738.0134.83Price / Book-0.353.687.644.62Net Income-$6.50M-$71.72M$3.19B$245.94M7 Day Performance3.59%-2.50%-2.11%-2.62%1 Month Performance-3.08%-0.32%-0.49%-2.15%1 Year Performance-30.80%-12.32%16.44%12.95% Scinai Immunotherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCNIScinai ImmunotherapeuticsN/A$3.46+2.4%N/A-28.2%$2.88MN/A-0.0120Gap UpCHROChromocell TherapeuticsN/A$1.88+8.7%N/A-64.9%$11.33MN/A0.004BCDABioCardia2.7949 of 5 stars$2.84+4.4%$25.00+780.3%-63.6%$11.23M$480,000.000.0040Gap DownAEONAEON Biopharma2.1923 of 5 stars$0.13-0.8%$5.00+3,776.0%-98.9%$11.20MN/A0.005Gap DownKPRXKiora Pharmaceuticals2.2185 of 5 stars$3.62+0.6%$10.00+176.2%-35.3%$11.07MN/A0.0010News CoverageTSBXTurnstone Biologics1.529 of 5 stars$0.41+6.0%$0.45+8.8%-84.1%$11.06M$19.31M0.0082Gap UpTLPHTalphera2.5599 of 5 stars$0.65+2.7%$4.33+568.7%-50.8%$11.04M$650,000.00-0.9419Gap UpBCLIBrainstorm Cell Therapeutics4.0694 of 5 stars$1.86+3.3%$30.00+1,512.9%-62.9%$10.60MN/A-0.3940Analyst ForecastNews CoveragePHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049CSCICOSCIENS BiopharmaN/A$2.76-2.5%N/AN/A$10.43M$4.50M-0.2320AIMDAinos0.4108 of 5 stars$0.74+1.2%N/A-23.5%$10.41M$120,000.000.0040Gap Up Related Companies and Tools Related Companies Chromocell Therapeutics Alternatives BioCardia Alternatives AEON Biopharma Alternatives Kiora Pharmaceuticals Alternatives Turnstone Biologics Alternatives Talphera Alternatives Brainstorm Cell Therapeutics Alternatives PHAXIAM Therapeutics Alternatives COSCIENS Biopharma Alternatives Ainos Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SCNI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scinai Immunotherapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scinai Immunotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
